Washington Trust CO Bio Xcel Therapeutics, Inc. Transaction History

Washington Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$20.12 - $35.09 $5,030 - $8,772	-250 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$29.06 - $38.83 $17,436 - $23,298	-600 Reduced 70.59%	250 $7,000
Q4 2020 Feb 09, 2021	BUY	$42.46 - $56.58 $25,476 - $33,948	600 Added 240.0%	850 $39,000
Q3 2020 Nov 05, 2020	BUY	$37.44 - $64.63 $9,360 - $16,157	250 New	250 $11,000

5.21M

34.5K

59.4K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $47.9M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

Stay updated on Washington Trust CO with notifications on news.